Novo Nordisk Stock Forward View
| NVO Stock | USD 59.33 0.10 0.17% |
Novo Stock outlook is based on your current time horizon. Although Novo Nordisk's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Novo Nordisk's systematic risk associated with finding meaningful patterns of Novo Nordisk fundamentals over time.
As of today, The relative strength index (RSI) of Novo Nordisk's share price is at 57. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Novo Nordisk, making its price go up or down. Momentum 57
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth (0.27) | EPS Estimate Next Quarter 6.1067 | EPS Estimate Current Year 23.166 | EPS Estimate Next Year 22.3719 | Wall Street Target Price 59.166 |
Using Novo Nordisk hype-based prediction, you can estimate the value of Novo Nordisk AS from the perspective of Novo Nordisk response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Novo Nordisk using Novo Nordisk's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Novo using crowd psychology based on the activity and movement of Novo Nordisk's stock price.
Novo Nordisk Short Interest
An investor who is long Novo Nordisk may also wish to track short interest. As short interest increases, investors should be becoming more worried about Novo Nordisk and may potentially protect profits, hedge Novo Nordisk with its derivative instruments, or be ready for some potential downside.
200 Day MA 58.8968 | Short Percent 0.0084 | Short Ratio 1.45 | Shares Short Prior Month 28.5 M | 50 Day MA 52.7732 |
Novo Relative Strength Index
The Naive Prediction forecasted value of Novo Nordisk AS on the next trading day is expected to be 56.95 with a mean absolute deviation of 1.14 and the sum of the absolute errors of 69.46.Novo Nordisk AS Hype to Price Pattern
Investor biases related to Novo Nordisk's public news can be used to forecast risks associated with an investment in Novo. The trend in average sentiment can be used to explain how an investor holding Novo can time the market purely based on public headlines and social activities around Novo Nordisk AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Novo Nordisk's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Novo Nordisk.
Novo Nordisk Implied Volatility | 0.58 |
Novo Nordisk's implied volatility exposes the market's sentiment of Novo Nordisk AS stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novo Nordisk's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novo Nordisk stock will not fluctuate a lot when Novo Nordisk's options are near their expiration.
The Naive Prediction forecasted value of Novo Nordisk AS on the next trading day is expected to be 56.95 with a mean absolute deviation of 1.14 and the sum of the absolute errors of 69.46.
Novo Nordisk after-hype prediction price | USD 59.33 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections. Prediction based on Rule 16 of the current Novo contract
Based on the Rule 16, the options market is currently suggesting that Novo Nordisk AS will have an average daily up or down price movement of about 0.0363% per day over the life of the 2026-04-17 option contract. With Novo Nordisk trading at USD 59.33, that is roughly USD 0.0215 . If you think that the market is fully incorporating Novo Nordisk's daily price movement you should consider acquiring Novo Nordisk AS options at the current volatility level of 0.58%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Novo Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Novo Nordisk's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Novo Nordisk's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Novo Nordisk stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Novo Nordisk's open interest, investors have to compare it to Novo Nordisk's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Novo Nordisk is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Novo. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Novo Nordisk Additional Predictive Modules
Most predictive techniques to examine Novo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novo using various technical indicators. When you analyze Novo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Novo Nordisk Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Novo Nordisk's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 1985-12-31 | Previous Quarter 18.4 B | Current Value 32.1 B | Quarterly Volatility 8.2 B |
Novo Nordisk Naive Prediction Price Forecast For the 2nd of February
Given 90 days horizon, the Naive Prediction forecasted value of Novo Nordisk AS on the next trading day is expected to be 56.95 with a mean absolute deviation of 1.14, mean absolute percentage error of 1.79, and the sum of the absolute errors of 69.46.Please note that although there have been many attempts to predict Novo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Novo Nordisk's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Novo Nordisk Stock Forecast Pattern
| Backtest Novo Nordisk | Novo Nordisk Price Prediction | Buy or Sell Advice |
Novo Nordisk Forecasted Value
In the context of forecasting Novo Nordisk's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Novo Nordisk's downside and upside margins for the forecasting period are 54.07 and 59.84, respectively. We have considered Novo Nordisk's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Novo Nordisk stock data series using in forecasting. Note that when a statistical model is used to represent Novo Nordisk stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.6923 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.1387 |
| MAPE | Mean absolute percentage error | 0.022 |
| SAE | Sum of the absolute errors | 69.4618 |
Predictive Modules for Novo Nordisk
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novo Nordisk AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novo Nordisk's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Novo Nordisk After-Hype Price Density Analysis
As far as predicting the price of Novo Nordisk at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novo Nordisk or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Novo Nordisk, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Novo Nordisk Estimiated After-Hype Price Volatility
In the context of predicting Novo Nordisk's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novo Nordisk's historical news coverage. Novo Nordisk's after-hype downside and upside margins for the prediction period are 56.42 and 62.24, respectively. We have considered Novo Nordisk's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Novo Nordisk is very steady at this time. Analysis and calculation of next after-hype price of Novo Nordisk AS is based on 3 months time horizon.
Novo Nordisk Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Novo Nordisk is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novo Nordisk backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novo Nordisk, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 2.89 | 0.38 | 0.05 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
59.33 | 59.33 | 0.00 |
|
Novo Nordisk Hype Timeline
On the 1st of February Novo Nordisk AS is traded for 59.33. The entity has historical hype elasticity of 0.38, and average elasticity to hype of competition of -0.05. Novo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.35%. %. The volatility of related hype on Novo Nordisk is about 1888.89%, with the expected price after the next announcement by competition of 59.28. The company has Price/Earnings To Growth (PEG) ratio of 2.84. Novo Nordisk AS last dividend was issued on the 18th of August 2025. The entity had 2:1 split on the 20th of September 2023. Considering the 90-day investment horizon the next anticipated press release will be in about 5 days. Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections.Novo Nordisk Related Hype Analysis
Having access to credible news sources related to Novo Nordisk's direct competition is more important than ever and may enhance your ability to predict Novo Nordisk's future price movements. Getting to know how Novo Nordisk's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novo Nordisk may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRK | Merck Company | (0.91) | 8 per month | 1.13 | 0.19 | 3.59 | (1.98) | 8.09 | |
| NVS | Novartis AG ADR | 1.10 | 17 per month | 1.13 | 0.12 | 2.59 | (2.32) | 6.07 | |
| ABT | Abbott Laboratories | 0.93 | 24 per month | 0.00 | (0.15) | 1.82 | (2.05) | 13.37 | |
| AZN | AstraZeneca PLC | 1.09 | 7 per month | 1.31 | 0.09 | 2.62 | (2.37) | 8.81 | |
| GILD | Gilead Sciences | 4.67 | 8 per month | 1.34 | 0.12 | 3.01 | (2.41) | 6.70 | |
| PFE | Pfizer Inc | 0.07 | 8 per month | 1.15 | 0.08 | 2.24 | (2.24) | 7.97 | |
| TMO | Thermo Fisher Scientific | (11.70) | 8 per month | 1.10 | 0 | 2.43 | (2.11) | 5.76 | |
| AMGN | Amgen Inc | 2.92 | 8 per month | 1.17 | 0.13 | 3.47 | (2.59) | 11.18 | |
| SNY | Sanofi ADR | 0.93 | 8 per month | 0.00 | (0.13) | 1.87 | (2.19) | 5.92 | |
| GSK | GlaxoSmithKline PLC ADR | (0.63) | 9 per month | 0.93 | 0.16 | 2.38 | (1.83) | 8.39 |
Other Forecasting Options for Novo Nordisk
For every potential investor in Novo, whether a beginner or expert, Novo Nordisk's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Novo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Novo. Basic forecasting techniques help filter out the noise by identifying Novo Nordisk's price trends.Novo Nordisk Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novo Nordisk stock to make a market-neutral strategy. Peer analysis of Novo Nordisk could also be used in its relative valuation, which is a method of valuing Novo Nordisk by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Novo Nordisk Market Strength Events
Market strength indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk stock market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns.
Novo Nordisk Risk Indicators
The analysis of Novo Nordisk's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Novo Nordisk's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting novo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.15 | |||
| Semi Deviation | 2.02 | |||
| Standard Deviation | 2.84 | |||
| Variance | 8.08 | |||
| Downside Variance | 4.79 | |||
| Semi Variance | 4.07 | |||
| Expected Short fall | (2.55) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Novo Nordisk
The number of cover stories for Novo Nordisk depends on current market conditions and Novo Nordisk's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novo Nordisk is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novo Nordisk's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Novo Nordisk Short Properties
Novo Nordisk's future price predictability will typically decrease when Novo Nordisk's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novo Nordisk AS often depends not only on the future outlook of the potential Novo Nordisk's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novo Nordisk's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.5 B | |
| Cash And Short Term Investments | 26.3 B |
Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Pharmaceuticals sector continue expanding? Could Novo diversify its offerings? Factors like these will boost the valuation of Novo Nordisk. Anticipated expansion of Novo directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Novo Nordisk data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.27) | Dividend Share 11.65 | Earnings Share 3.76 | Revenue Per Share | Quarterly Revenue Growth 0.051 |
Understanding Novo Nordisk AS requires distinguishing between market price and book value, where the latter reflects Novo's accounting equity. The concept of intrinsic value—what Novo Nordisk's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Novo Nordisk's price substantially above or below its fundamental value.
It's important to distinguish between Novo Nordisk's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novo Nordisk should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Novo Nordisk's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.